Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis
Journal of Cystic Fibrosis · 2023
DOI: 10.1016/j.jcf.2023.04.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von L Schembri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK. Hauptthemen laut MEDLINE: Vitamin A, Cystic Fibrosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Children with cystic fibrosis are at risk of fat-soluble vitamin deficiency. CFTR modulators positively effect nutritional status. This study aimed to assess changes in serum vitamins A, D & E after starting ETI therapy to ensure levels were not abnormally high. METHODS: Retrospective review of annual assessment data over 3½ years, before and after starting ETI in a specialist paediatric CF centre, including vitamin levels. RESULTS: 54 eligible patients were included, aged 5-15 yrs (median age 11.5). Median time to post measurements was 171 days. Median vitamin A was increased (1.38 to 1.63 µmol/L, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK.
- Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
- Department of Paediatric Pharmacy, Royal Brompton Hospital, London, UK.
- Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK. Electronic address: i.balfourlynn@ic.ac.uk.
Zitieren
APA
Schembri, L., Warraich, S., Bentley, S., Carr, S. B., & Balfour-Lynn, I. M. (2023). Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.04.019
Vancouver
Schembri L, Warraich S, Bentley S, Carr SB, Balfour-Lynn IM. Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.04.019
BibTeX
@article{Schembri2023,
author = {Schembri, L and Warraich, S and Bentley, S and Carr, S B and Balfour-Lynn, I M},
title = {Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2023},
doi = {10.1016/j.jcf.2023.04.019}
}
EUVIMED